Q1 2025 Holdings
Filed 2025-05-15 | 202 holdings | $1.8B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $126.1M | 2,454,797 | 7.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $99.5M | 3,961,797 | 5.5% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $80.6M | 10,029,500 | 4.5% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $74.6M | 5,750,000 | 4.1% |
| Evolus Inc(EOLS) | COM | 30052C107 | $60.1M | 4,997,399 | 3.3% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $57.0M | 4,941,798 | 3.2% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $56.8M | 1,915,708 | 3.1% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $55.7M | 1,237,107 | 3.1% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $51.0M | 1,000,000 | 2.8% |
| Kiniksa Pharmaceuticals Intl(KNSA) | ORD SHS CL A | G52694109 | $47.1M | 2,118,579 | 2.6% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $37.6M | 2,792,925 | 2.1% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $33.1M | 2,050,000 | 1.8% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $29.0M | 220,000 | 1.6% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $28.7M | 1,545,153 | 1.6% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $28.3M | 2,900,000 | 1.6% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $28.2M | 830,000 | 1.6% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $24.9M | 1,500,000 | 1.4% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $24.6M | 270,000 | 1.4% |
| Acelyrin Inc | COM | 00445A100 | $24.3M | 9,818,115 | 1.3% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $23.6M | 190,000 | 1.3% |
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $21.3M | 317,500 | 1.2% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $21.1M | 8,068,058 | 1.2% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $21.0M | 11,052,632 | 1.2% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $20.8M | 1,050,000 | 1.2% |
| Lenz Therapeutics Inc(LENZ) | COM | 52635N103 | $19.7M | 766,940 | 1.1% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $18.4M | 250,000 | 1.0% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $17.7M | 1,200,000 | 1.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $16.6M | 150,000 | 0.9% |
| Avadel Pharmaceuticals PLC | COM SHS | G29687103 | $16.4M | 2,097,500 | 0.9% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $16.1M | 2,689,200 | 0.9% |
| Meta Platforms Inc(META) | CL A | 30303M102 | $15.9M | 27,575 | 0.9% |
| GSK PLC(GSK) | SPONSORED ADR | 37733W204 | $15.5M | 400,000 | 0.9% |
| Nvidia Corporation(NVDA) | COM | 67066G104 | $15.5M | 142,569 | 0.9% |
| Sanofi(SNY) | SPONSORED ADR | 80105N105 | $15.0M | 270,000 | 0.8% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $14.4M | 4,800,000 | 0.8% |
| Altimmune Inc(ALT) | COM NEW | 02155H200 | $13.8M | 2,750,000 | 0.8% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $13.1M | 1,100,000 | 0.7% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $13.0M | 7,055,576 | 0.7% |
| Cargo Therapeutics Inc(CRGX) | COM | 14179K101 | $12.5M | 3,059,630 | 0.7% |
| Cybin Inc(HELP) | COM NEW | 23256X407 | $11.6M | 1,830,097 | 0.6% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $11.3M | 300,000 | 0.6% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $11.2M | 1,100,000 | 0.6% |
| Teladoc Health Inc(TDOC) | COM | 87918A105 | $11.1M | 1,400,000 | 0.6% |
| Journey MED Corp(DERM) | COM | 48115J109 | $10.9M | 1,854,596 | 0.6% |
| Vanda Pharmaceuticals Inc(VNDA) | COM | 921659108 | $10.8M | 2,353,307 | 0.6% |
| Beigene LTD(ONC) | SPONSORED ADS | 07725L102 | $10.1M | 37,000 | 0.6% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $9.8M | 1,393,800 | 0.5% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $9.3M | 281,200 | 0.5% |
| Alibaba Group Holding LTD ADR(BABA) | SPONSORED ADS | 01609W102 | $9.3M | 70,000 | 0.5% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $9.1M | 266,500 | 0.5% |